Options Medical Weight Loss Clinic
1147 S Wabash Ave • Chicago, IL 60605
⚙ Telehealth
🔍 Researched
✓ Google Verified
Data last verified: March 2026
Data Verification Status
100% complete
Name & Address via Google
Phone via Google
Website via Google
Medications from website
Telehealth from website
Pricing from website
About
Options Medical Weight Loss Clinic in Chicago, Illinois offers semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) for physician-guided weight loss. Appointments are available through both in-person visits and virtual telehealth consultations. Highly rated at 4.7 stars across 532 reviews.
GLP-1 Medications Offered
Based on information found on the clinic's website
This Clinic May Be a Good Fit If You
- Prefer telehealth consultations from home
- Want in-person visits
- Are looking for Semaglutide, Tirzepatide
- Want medications shipped to your door
- Want a free initial consultation
- Want compounded medication options
- Want transparent, upfront pricing
Clinic Details
Phone(312) 360-1604 ↗
WebsiteVisit Website ↗
Visit Type
In-Person & Telehealth
per clinic website
Medication Type
Compounded
Consultation
Free consultation
Delivery
Medications shipped to your door
Hours
| Mon | 7:00 AM – 4:00 PM |
| Tue | 7:00 AM – 5:30 PM |
| Wed | 7:00 AM – 5:30 PM |
| Thu | 7:00 AM – 5:30 PM |
| Fri | 7:00 AM – 4:00 PM |
Own this clinic? Claim your free listing to update info and receive patient inquiries, or upgrade to Premium for featured placement.
Learn More About GLP-1 Weight Loss
Semaglutide Guide
Ozempic, Wegovy — dosing, side effects, costs
Tirzepatide Guide
Mounjaro, Zepbound — dosing, side effects, costs
Insurance Coverage
Check if your plan covers GLP-1 medications
Savings Calculator
Estimate your monthly medication costs
BMI Calculator
Check your eligibility for GLP-1 treatment
Compare Medications
Side-by-side comparison of all GLP-1 options
Pricing Guide
What to expect for GLP-1 medication costs
Patient Reviews
This clinic has 532 Google reviews (rated 4.7/5). No reviews submitted on GlobalGLP1 yet — be the first to share your experience.